Sage Journals: Discover world-class research

Abstract

We present the case of a 34-year-old woman with Klippel-Feil syndrome who developed progressive generalized dystonia of unclear etiology, resulting in intractable pain despite aggressive medical and surgical interventions. Ultimately, palliative sedation was required to relieve suffering. Herein, we describe ethical considerations including defining sedation, determining prognosis in the setting of an undefined neurodegenerative condition, and use of treatments that concurrently might prolong or alter end-of-life trajectory. We highlight pertinent literature and how it may be applied in challenging and unique clinical situations. Finally, we discuss the need for expert multidisciplinary involvement when implementing palliative sedation and illustrate that procedures and rules need to be interpreted to deliver optimal patient-centered plan of care.

Keywords

palliative sedation end of life active dying medical ethics artificial nutrition and hydration central pain syndrome dystonia deep brain stimulation

Get full access to this article

View all access options for this article.

References

AAHPM Board of Directors. Statement on Palliative Sedation; 2006. Web site. http://www.aahpm.org/positions/default/sedation.html. Accessed 4 October 2014.

de Graeff

Dean

. Palliative sedation therapy in the last weeks of life: a literature review and recommendations for standards. J Palliat Med. 2007;10 (1):67–85.

Kirk

Mahon

. National Hospice and Palliative Care Organization (NHPCO) position statement and commentary on the use of palliative sedation in imminently dying terminally ill patients. J Pain Symptom Manage. 2010;39 (5):914–923.

American Medical Association Council on Ethical and Judicial Affairs. Opinion 2.201—Sedation to Unconsciousness in End-of-Life Care, Code of Medical Ethics of the American Medical Association. 2014-2015 ed. Chicago IL: AMA Press; 2015.

Belgrade

Hall

. Dexmedetomidine infusion for the management of opioid-induced hyperalgesia. Pain Med. 2010;11 (12):1819–1826.

Roberts

Wozencraft

Coyne

Smith

. Dexmedetomidine as an adjuvant analgesic for intractable cancer pain. J Palliat Med. 2011;14 (3):371–373.

Olsen

Swetz

Mueller

. Ethical decision making with end-of-life care: palliative sedation and withholding or withdrawing life-sustaining treatments. Mayo Clin Proc. 2010;85 (10):949–954.

Maltoni

Miccinesi

Morino

. Prospective observational Italian study on palliative sedation in two hospice settings: differences in casemixes and clinical care. Support Care Cancer. 2012;20 (11):2829–2836.

Maltoni

Scarpi

Rosati

. Palliative sedation in end-of-life care and survival: a systematic review. J Clin Oncol. 2012;30 (12):1378–1383.

10.

Cherny

. ESMO Clinical Practice Guidelines for the management of refractory symptoms at the end of life and the use of palliative sedationdagger. Ann Oncol. 2014;25(suppl 3):iii143–iii152.

11.

Cherny

Radbruch

. European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliat Med. 2009;23 (7):581–593.

12.

Chater

Viola

Paterson

Jarvis

. Sedation for intractable distress in the dying--a survey of experts. Palliat Med. 1998;12 (4):255–269.

13.

Quill

Byock

. Responding to intractable terminal suffering: the role of terminal sedation and voluntary refusal of food and fluids. ACP-ASIM End-of-Life Care Consensus Panel. American College of Physicians-American Society of Internal Medicine. Ann Intern Med. 2000;132 (5):408–414.

14.

Ganzini

. Artificial nutrition and hydration at the end of life: ethics and evidence. Palliat Support Care. 2006;4 (2):135–143.

15.

Bruera

Hui

Dalal

. Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo-controlled randomized trial. J Clin Oncol. 2013;31 (1):111–118.

16.

Sessler

Gosnell

Grap

. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166(10):1338–1344.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.16 MB